Catalent Pharma Solutions Announces Investor Day

Catalent Pharma Solutions, Inc. announced today that it will host
a business update and facility tour on Friday, May 16, 2008, in St.
Petersburg, Florida. The agenda tentatively includes a business
overview presentation from John Lowry, the President and Chief
Executive Officer of Catalent; a financial review from Matthew Walsh,
the newly appointed Senior Vice President and Chief Financial Officer;
an overview of the Oral Technologies segment from Thomas Stuart, its
President; and a tour of Catalent´s best-in-class softgel
manufacturing facility.

Investors, analysts, and other interested parties are invited to
submit requests to attend the meeting at
www.catalent.com/InvestorDay08.

All presentations will be available the day of the meeting via
webcast from the Investor Center page at www.catalent.com, and via
replay after the meeting.

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions
is one of the leading providers of advanced technologies, and
development, manufacturing and packaging services for pharmaceutical,
biotechnology and consumer healthcare companies in nearly 100
countries. Catalent applies its local market expertise and technical
creativity to advance treatments, change markets and enhance patient
outcomes. Catalent employs approximately 10,000 at more than 30
facilities worldwide and generates more than $1.7 billion of annual
revenue. For more information, visit www.catalent.com.